We have the ability to get something done very quickly and at scale: Murali Neelakantan on production of COVID-19 vaccines in India

Neelakantan sheds light on what role Intellectual Property Rights play on how fast vaccines can be produced at a large scale, the gaps in India's COVID-19 vaccination policy, and more.

Almost halfway through 2021, India finds itself in the midst of a healthcare crisis effected by the proliferation of the second wave of COVID-19.

Want to read the full story?

We’re glad you’re enjoying this story. Subscribe to any of our plans to continue reading the story.

Already have an account? Sign In
No stories found.
Bar and Bench - Indian Legal news